| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.079 | 0.005 |